Physician profile
Katlynn E Burger
NPI 1154777555
$2,240.66
in general payments reported to CMS, 2019-2025
21 companies · $565 in 2025
The $565 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $513 · 2022: $272 · 2023: $466 · 2024: $424 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $690.79 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $240.29 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $213.29 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $181.85 | 2023-2025 | Assure Wcd |
| Amarin Pharma, INC. | $124.74 | 2021 | |
| Merck Sharp & Dohme LLC | $107.29 | 2021-2023 | Verquvo |
| Scpharmaceuticals INC. | $91.82 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $91.10 | 2021-2025 | Brilinta, Farxiga |
| Pfizer INC. | $73.08 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $71.68 | 2023 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $60.90 | 2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $52.87 | 2023-2024 | Xarelto |
| Kiniksa Pharmaceuticals, Ltd. | $41.57 | 2021-2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $40.31 | 2023-2024 | |
| Chiesi USA, INC. | $38.77 | 2022-2025 | Kengreal |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $23.76 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $23.55 | 2021 | |
| Cordis US Corp. | $22.30 | 2024 | Radial 360 |
| Bayer Healthcare Pharmaceuticals INC. | $17.26 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $17.17 | 2024 | Arcalyst |
| Angiodynamics, INC. | $16.27 | 2023 | Auryon Laser System 100-120 Vac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katlynn Burger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.